<div id="readability-page-1"><p>Interval Partners LP boosted its position in shares of  Globe Life Inc. (NYSE:GL - Free Report) by 28.5% during the 3rd quarter, according to its most recent 13F filing with the Securities &amp; Exchange Commission. The firm owned 137,105 shares of the company's stock after purchasing an additional 30,390 shares during the quarter. Interval Partners LP owned about 0.17% of Globe Life worth $19,602,000 as of its most recent filing with the Securities &amp; Exchange Commission.</p><ul><li>From Glass Maker to AI Kingmaker: Corning’s Pivot</li></ul><p>A number of other institutional investors and hedge funds have also bought and sold shares of GL. Invesco Ltd. lifted its holdings in shares of  Globe Life by 3.9% in the 2nd quarter. Invesco Ltd. now owns 3,921,439 shares of the company's stock worth $487,396,000 after buying an additional 147,644 shares during the period.  Geode Capital Management LLC grew its position in shares of  Globe Life by 2.9% during the 2nd quarter. Geode Capital Management LLC now owns 2,722,768 shares of the company's stock worth $339,875,000 after buying an additional 76,995 shares in the last quarter.  Dimensional Fund Advisors LP increased its stake in shares of  Globe Life by 2.9% during the third quarter. Dimensional Fund Advisors LP now owns 2,076,232 shares of the company's stock valued at $296,841,000 after buying an additional 59,353 shares during the period.  AQR Capital Management LLC raised its holdings in shares of  Globe Life by 98.6% in the second quarter. AQR Capital Management LLC now owns 1,402,690 shares of the company's stock valued at $174,340,000 after acquiring an additional 696,548 shares in the last quarter.  Finally, Norges Bank bought a new stake in shares of  Globe Life in the second quarter valued at about $157,722,000. 81.61% of the stock is owned by institutional investors. </p><h2>Globe Life Trading Down 0.2%</h2><p>Globe Life stock opened at $138.51 on Friday. The company has a debt-to-equity ratio of 0.39, a quick ratio of 0.07 and a current ratio of 0.07. The stock has a market cap of $10.89 billion, a PE ratio of 9.84 and a beta of 0.46. The stock has a 50-day moving average of $142.07 and a two-hundred day moving average of $139.01. Globe Life Inc. has a one year low of $109.38 and a one year high of $152.71. </p><ul><li>MarketBeat Week in Review – 02/16 - 02/20</li></ul><p>Globe Life (NYSE:GL - Get Free Report) last issued its quarterly earnings results on Wednesday, February 4th. The company reported $3.39 earnings per share for the quarter, missing analysts' consensus estimates of $3.44 by ($0.05). Globe Life had a return on equity of 21.30% and a net margin of 19.37%.The business had revenue of $1.52 billion for the quarter, compared to analysts' expectations of $1.53 billion. During the same quarter in the previous year, the firm posted $3.14 EPS. Globe Life's revenue was up 3.6% on a year-over-year basis. Globe Life has set its FY 2026 guidance at 14.950-15.650 EPS.  On average, research analysts anticipate that  Globe Life Inc. will post 13.87 EPS for the current fiscal year. </p><h2>Globe Life Increases Dividend</h2><p>The business also recently announced a quarterly dividend, which will be paid on Friday, May 1st. Shareholders of record on Friday, April 3rd will be given a dividend of $0.33 per share. The ex-dividend date of this dividend is Thursday, April 2nd. This represents a $1.32 annualized dividend and a yield of 1.0%. This is a boost from Globe Life's previous quarterly dividend of $0.27. Globe Life's payout ratio is presently 7.67%. </p><h2>Wall Street Analysts Forecast Growth</h2><ul><li>Corning’s Surprise AI Boom: Is It Already Too Late to Buy?</li></ul><p>A number of research firms have commented on GL. TD Cowen  reissued a &#34;buy&#34; rating on shares of Globe Life in a research report on Thursday, December 11th. Morgan Stanley  reaffirmed an &#34;overweight&#34; rating and issued a $176.00 price target on shares of Globe Life in a research report on Monday, December 15th. Truist Financial increased their price objective on shares of Globe Life from $158.00 to $180.00 and gave the company a &#34;buy&#34; rating in a research note on Friday, February 6th. Wells Fargo &amp; Company lifted their price objective on shares of Globe Life from $170.00 to $171.00 and gave the company an &#34;overweight&#34; rating in a report on Wednesday, February 25th. Finally, JPMorgan Chase &amp; Co. boosted their price objective on shares of Globe Life from $180.00 to $181.00 and gave the stock an &#34;overweight&#34; rating in a research note on Thursday, February 5th. Eight equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company's stock. According to data from MarketBeat.com, the company presently has a consensus rating of &#34;Moderate Buy&#34; and an average target price of $171.33.</p><p><b>View Our Latest Research Report on Globe Life</b></p><h2>Insider Buying and Selling at Globe Life</h2><p>In other news, Director Mark A. Blinn sold 1,750 shares of the business's stock in a transaction on Friday, February 6th. The shares were sold at an average price of $147.91, for a total transaction of $258,842.50. Following the sale, the director directly owned 3,372 shares of the company's stock, valued at $498,752.52. The trade was a 34.17% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities &amp; Exchange Commission, which is available through this hyperlink. Also, CEO James Matthew Darden sold 18,318 shares of the company's stock in a transaction on Wednesday, March 4th. The shares were sold at an average price of $145.10, for a total value of $2,657,941.80. Following the completion of the transaction, the chief executive officer directly owned 51,093 shares in the company, valued at approximately $7,413,594.30. The trade was a 26.39% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 92,186 shares of company stock worth $13,358,379 in the last three months. 1.51% of the stock is owned by company insiders. </p><h2>Globe Life Profile</h2> (Free Report)<p>Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.  </p><p>The company's product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.</p><h2>Further Reading</h2><ul><li>Five stocks we like better than Globe Life</li><li>A personal warning from Martin Weiss (Please read)</li><li>SpaceX IPO Confirmed: Claim Your Stake Today</li><li>Forget oil — this changes everything about American energy...</li><li>$30 stock to buy before Starlink goes public (WATCH NOW!)</li><li>This coin has everything going for it</li></ul><p><strong>Want to see what other hedge funds are holding GL?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Globe Life Inc. (NYSE:GL - Free Report).</p><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUdM?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUdM"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Globe Life Right Now?</h2><p>Before you consider Globe Life, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Globe Life wasn't on the list.</p><p>While Globe Life currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

<p>Interval Partners LP increased its stake in Globe Life Inc. by 28.5% in Q3, acquiring an additional 30,390 shares, bringing its total to 137,105 shares valued at $19.6 million. Other institutional investors also raised their holdings. Globe Life's stock opened at $138.51, with a market cap of $10.89 billion. The company reported Q4 earnings of $3.39 per share, missing estimates, and announced a dividend increase to $0.33 per share. Analysts maintain a positive outlook with several buy ratings and price targets ranging from $171 to $181.</p>

Interval Partners LP Purchases 30,390 Shares of Globe Life Inc. $GL